Data, AI And Machine Learning Are Propelling Clinical Trials Data Analysis To New Heights

 
• By Ashley Yeo

The quality of clinical trials and data analysis have come a long way in the past 10 years – and even in the past three, says Christian Hebenstreit of Medidata, the cloud-based platform that supports pharma and medtech companies through clinical studies ahead of their commercial uptake. The buzzwords of the fairly recent past are now being applied as real tools in the clinical trials arena, and look set to transform the sector.

The London arm of Medidata NEXT, the seven-venue awareness event for clinical trials professionals around the globe, is humming with industry players keen to hear how they can use Medidata Solutions Inc.'s Clinical Cloud tool, which combines science and the operation of clinical trials. At the podium, US product development executive Dave Metz is explaining the MEDS (Medidata Enterprise Data Store) element of the offering: the repository of clinical and operational data that are the basis of clinical process decision-making.

Metz's tone is irrepressibly upbeat: Medidata's service offerings to clinical clients are increasing in speed and quality across the industry. And investors are similarly optimistic: the group has something of a financial tailwind, with Q1 2018 revenues rising 17% to over $149 million and shares not far off their all-time high of 10 months ago

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation

More from In Vivo